Liver biopsy showdown: EUS or needle – patients decide!
NCT ID NCT07506642
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared how patients feel about two ways to take a small sample of liver tissue: one using a needle through the skin (percutaneous) and another using a thin tube through the mouth (EUS-guided). 102 adults with chronic liver disease were randomly assigned to one method and then filled out a questionnaire about their experience. The goal was to find out which method patients tolerate better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE (CLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Muenster
Münster, North Rhine-Westphalia, 48149, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
- Blood type no barrier? study tests liver transplant success across ABO barriers
- Scientists hunt for clues in body fluids to predict liver failure outcomes
- Blood transfusion strategy could be refined for liver patients
- Liver's Post-Meal secrets could unlock new fatty liver treatments